Roberto Roberto Clarizia

Dr. Roberto Roberto Clarizia

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
CACarlo Alviggi
Carlo Alviggi
KPKim Pettersson
Kim Pettersson
SLsalvatore longobardi
salvatore longobardi
CAClaus Yding Andersen
Claus Yding Andersen
ACAlessandro Conforti
Alessandro Conforti
PHPeter Humaidan
Peter Humaidan
V-betaLH is a common genetic variant of LH caused by two polymorphic base changes in the beta subunit gene, altering the amino acid sequence (Trp8Arg and Ile15Thr). In a previous-preliminary trial performed in women undergoing IVF, it was demonstrated that carriers of v-betaLH show sub-optimal ovarian response to a standard long GnRH-agonist down -regulation protocol when stimulated with pure recombinant FSH (r-hFSH). The aim of this study was to confirm the hypothesis that women with v-betaLH display hypo-sensitivity to exogenous FSH in a larger IVF population and to explore the frequency of this variant in a Danish female population. In the present study, the effect of v-betaLH was retrospectively investigated in a larger series of women undergoing controlled ovarian stimulation (COS) and, for the first time, in a Danish IVF population. A total of 220 normogonadotrophic women following a long GnRH-agonist down-regulation protocol received an individualized dose of r-hFSH (100 IU and 375 IU s.c. daily) according to antral follicle count, baseline FSH, body mass index and age. The LH genotype was assessed in all patients by immunofluorometric assay. V-betaLH was present in 11% of patients, whereas the allelic frequency was 12%. The study population was divided into two groups according to their LH genotype. Group A consisted of 196 wt/wt women. Group B included 24 individuals with v-betaLH (21 heterozygous and 3 homozygous). No statistically significant differences in the mean number of oocytes retrieved, fertilization rate and pregnancy rate per cycle were observed between groups. However, Group B received a significantly higher cumulative-dose of r-hFSH than Group A (2435.86 +/− 932.8 IU versus 1959.8 +/− 736.45 p = 0.048). When one-way ANOVA in a within design was applied, the LH genotype had a statistically significant effect (p < 0.01) on the cumulative dose of r-hFSH, showing a progressive increase from wt/wt (1959.8 +/− 736.45 IU) to v-betaLH hetero- (2267.5 +/− 824.3) and homozygotic women (3558.3 +/− 970.9). These results confirm that carriers exhibit hypo-sensitivity to exogenous FSH during COS, documenting that the frequency of v-betaLH in Denmark is similar to a number of European countries.

20 January 2010 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
MCMarcello Ceccaroni
Marcello Ceccaroni
Roberto Roberto ClariziaRoberto Roberto Clarizia
Roberto Roberto Clarizia
CACarlo Alboni
Carlo Alboni
GRGiacomo Ruffo
Giacomo Ruffo
FBFrancesco Bruni
Francesco Bruni
LMLuca Minelli
Luca Minelli

1 November 2010 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
MCMarcello Ceccaroni
Marcello Ceccaroni
Roberto Roberto ClariziaRoberto Roberto Clarizia
Roberto Roberto Clarizia
APAngelo Placci
Angelo Placci

1 March 2021 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
Roberto Roberto ClariziaRoberto Roberto Clarizia
Roberto Roberto Clarizia
TCTommaso Capezzuoli
Tommaso Capezzuoli
MCMatteo Ceccarello
Matteo Ceccarello
CZCarlotta Zorzi
Carlotta Zorzi
ASAnna Katarzyna Stepniewska
Anna Katarzyna Stepniewska
MCMarcello Ceccaroni
Marcello Ceccaroni

1 February 2012
Verified
Journal Article
Closed access
MCMarcello Ceccaroni
Marcello Ceccaroni
GRGiovanni Roviglione
Giovanni Roviglione
ESEmanuela Spagnolo
Emanuela Spagnolo
Paolo CasadioPaolo Casadio
Paolo Casadio
Roberto Roberto ClariziaRoberto Roberto Clarizia
Roberto Roberto Clarizia
GAGiovanni Aletti
Giovanni Aletti

12 December 2016 in Seminars in Reproductive Medicine
Verified
Journal Article
Closed access
PDF file
GBGiuliano Moysés Borrelli
Giuliano Moysés Borrelli
Roberto Roberto ClariziaRoberto Roberto Clarizia
Roberto Roberto Clarizia
RKRosanne Marie Kho
Rosanne Marie Kho
MCMarcello Ceccaroni
Marcello Ceccaroni
MAMauricio Simões Abrão
Mauricio Simões Abrão
Endometriosis has clearly three distinct clinical presentations and deep endometriosis, especially compromising the rectosigmoid is probably the most concerning one for both patients and surgeons. Currently, with the available tools, it is mandatory to have a precise diagnostic of this type of disease prior to indication of treatment. Strategies to manage this form of endometriosis will take into account several involved aspects, such as age of the patient, reproductive desire or infertility, clinical symptoms, as well as the extension and localization of the disease. Treatment could vary from more conservative to more radical depending on those aspects. As we pointed out in this article, the key to manage colorectal endometriosis is to start with a good diagnosis. Knowing exactly what is the extension and localization of the disease and knowing the patient's wishes as well as the clinical complaints, surgeons are able to define the best option for each patient. Critical points should always be discussed; for example, patients chosen to have clinical treatment should be aware of important issues regarding the follow-up, while patients undergoing surgery must be advised about all surgical possibilities and related complications.